Frontage Laboratories has acquired Concord Biosciences, formerly known as Ricerca Biosciences, a preclinical contract research organization (CRO).    Concord Bio supports the pharmaceutical, agricultural, chemical and animal health industries with drug safety, metabolism, bioanalytical, residue and environmental fate studies.   “We have committed to build a global CRO company with integrated services,” said Dr. Song Li, founder and chief executive officer, Frontage Laborato...